Heavy/light chain immunoparesis identifies systemic AL amyloidosis patients with poor survival outcomes

S. Sachchithanantham,O. Berlanga,A. Alvi,N. Wassef,S. Mahmood, R. Sayeed,J. Gillmore,H. Lachmann,C. Whelan,P. Hawkins,A. Wechalekar

Clinical Lymphoma, Myeloma & Leukemia（2015）

引用 0|浏览15

暂无评分

摘要

e192 PO-193 Heavy/light chain immunoparesis identifies systemic AL amyloidosis patients with poor survival outcomes S. Sachchithanantham, O. Berlanga, A. Alvi, N. Wassef, S. Mahmood, R. Sayeed, J. Gillmore, H. Lachmann, C. Whelan, P. Hawkins, A. Wechalekar National Amyloidosis Centre, University College London Medical School, London, UK; The Binding Ste Group Ltd, Birmingham, UK; Department of Biochemistry, Royal Free London NHS Foundation trust, London, UK

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要